The global cosmetic surgery and procedure market size was estimated at USD 112.08 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 14.7% from 2023 to 2030. Manufacturers coming up with innovative aesthetic devices has led to an increased demand for aesthetic treatments in recent years. The introduction of technologically advanced products, such as non-invasive body contouring systems, that use fat-freezing technology, is expected to create lucrative growth opportunities. Manufacturers' development of cutting-edge aesthetic equipment has recently raised the demand for aesthetic procedures. For instance, in 2021 Allergen Aesthetics a subsidiary of AbbVie Inc. announced their next-generation fat reduction system, Coolsculpting Elite, with applicators made to compliment the body's natural curves.
The cosmetic surgery and procedures market has witnessed exponential growth in the past decade due to rapid technological advancement in devices and techniques. The growing awareness regarding cosmetic surgery and the fact that people want to feel comfortable in their own skin is a driving factor for the market growth. The International Society of Aesthetic Plastic Surgery (ISAPS) announced the findings from its yearly global survey on aesthetic/cosmetic treatments, which showed a 19.3% increase in plastic surgery treatments overall in 2021, with more than 12.8 million surgical and 17.5 million non-surgical procedures carried out globally.
The popularity of non-invasive procedures, such as soft tissue fillers and Botox injections is growing as they are safe and reversible as compared to invasive procedures. The lower cost of non-invasive procedures and the convenience for people to resume their everyday life, as early as possible accounts for its high demand. In 2022, Cutera received Food and Drug Administration (FDA) clearance launched for AviClear, the first and only laser for the treatment of acne. AviClear has shown a significant reduction in acne in just three, 30-minute sessions in clinical research.
The COVID-19 pandemic significantly impacted the aesthetics medicine market. Initially, social distancing and sudden cuts in consumers' income levels had negatively affected the market. It witnessed negative growth for a few months due to factors such as temporary & permanent closures of beauty clinics/centers, decline in product demand, limited operations of centers, and manufacturing & supply chain disruption. However, the market gained momentum with Botox being one of the most preferred procedures. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined.
Thus, the market has witnessed a spike during the past few months and it is expected to be in high demand throughout the forecasted period. Growing fitness consciousness to look young has increased the demand for aesthetic treatments in developing countries. Aesthetic procedures like Botox injections, nose reshaping, and liposuction are gaining consumers’ interest in South Korea and India.
Based on procedure types, the market had been further segmented into invasive and non-invasive procedures. The non-invasive segment dominated the market with a revenue share of 54.7% in 2022. The sector is anticipated to continue to retain its dominance and grow at thefastestCAGR of 15.4% over the forecast period. Less pain, instant results, and low cost are some of the factors that have increased the demand for non-invasive procedures at a global level. Popular non-invasive procedures include Botox injections, soft tissue fillers, and chemical peels.
In June 2022, Cynosure announced the launch of the PicoSure Pro device, the latest update to the company’s PicoSure system. PicoSure Pro device utilizes pressure to provide effective and safe treatments for skin revitalization and unwanted pigmentation for all types of skin.
Apart from this, in October 2022 Abbive Inc.’s VOLUX XC under its Juvéderm filler range received FDA approval. It is a hyaluronic acid gel filler that is extremely cohesive. Volux is the sixth product to be launched in the Juvéderm filler range, for jawline improvement, which encompasses the chin and jaw region. Invasive procedures, such as liposuction, breast augmentation, and nose reshaping, are some of the popular aesthetic procedures. The growing focus on physical appearance has increased the demand for invasive procedures.
Based on age group, the 30-54 segment held the largest revenue share of 43.5% in 2022. It is expected to grow at the fastest CAGR of 15.2% over the forecast period. According to the American Society of Plastic Surgeon’s (ASPS) Insights and Trends Report Cosmetic Surgery 2022, the age group between 30-45 is opting for cosmetic procedures such as liposuction, tummy tuck, breast augmentation, breast enlargement, and cheek implants. While people falling in the age bracket above 45 are opting for advanced invasive procedures like eyelid surgeries and facelifts.
The 13-29 age group segment held the second largest market share of 36.9% in 2022 and is expected to grow at a CAGR of 14.9% over the forecast period. Teenagers are suffering from low self-esteem, depression, and anxiety due to an obsession with celebrity/influencer culture driven by social networking platforms. The most common procedures being opted for them include acne & acne scars, breast augmentation, rhinoplasty, and others.
Based on gender, the female segment held the largest market share of 85.9% in 2022 and is expected to grow at a CAGR of 14.5% over the forecast period due to the growing desire for a flawless physical appearance in women. The demand for cosmetic surgery operations has increased as people place more and more importance on having the ideal body structure. This covers surgeries on eyelids, lips, nose, cheekbones, and jawlines that directly affect a person's appearance.
The male segment is expected to grow at the fastest CAGR of 15.8% over the forecast period. This is owing to the growing desire for ideal aesthetic dimensions among men. The number of people who suffer from obesity has increased as contemporary lifestyles and the consumption of unhealthy food have become more common. The most common procedures being opted for by men include liposuction, surgery involving genitals, and others.
North America accounted for the largest market share of 35.4% in 2022. The presenceof certified and trained cosmetic surgeons in the region, the increasing frequency of skin problems, and the region's advanced healthcare infrastructure are some of the factors contributing to market expansion. ASPS analyzed the growth in cosmetic surgery procedures from 2000 to 2018 and suggested that the use of Botox injections increased by 845%, and at the same time breast augmentation procedures increased by 48%. Thus, North America is expected to be one of the key revenue generators for cosmetic surgery device manufacturers in the coming years too.
Asia Pacific, the market for cosmetic surgery and procedure market is projected to witness the fastest CAGR of 16.5% during the forecast period. The expansion of cosmetic surgery facilities in developing nations, rising healthcare costs, an aging population, and an increased emphasis on aesthetics are some of the major drivers of the regional industry. The demand for cosmetic procedures in China has increased recently due to the country's growth in obesity rate, which has resulted in people opting for more extreme weight-loss techniques like liposuction.
Apart from this, the number of cosmetic procedures conducted in Japan is on the rise, based on the International Society of Aesthetic Plastic Surgery (ISAPS) the most popular medical procedures in the country were dermal fillers, botulinum toxin, and eyelid surgery. South Korea is expected to be the hub for cosmetic procedures in the region and the availability of technologically advanced products, increasing admiration for large eyes double eyelids, and an increasing emphasis on physical appearance are some of the factors driving the market growth.
The global market is highly fragmented with many local players competing with international players. However, a strict regulatory approval process is challenging the entry of new products into the market. Primary parameters affecting the competitive nature are the rapid adoption of advanced devices for improved treatment and technological advancement.
Leading players are undertaking strategies such as mergers & acquisitions and product launches to gain maximum market share. For instance, in August 2022, Airsculpt Technologies launched AirSculpt Smooth, an FDA-approved cellulite removal tool. AirSculpt Smooth helps eliminate stubborn cellulite dimples. It uses no scalpels, needles, or stitches is performed while the patient is awake, and ensures that the patient returns to regular activities in 24 to 48 hours. Some prominent players in the global cosmetic surgery and procedure market include:
AbbVie Inc.
Cynosure
Evolus Inc.
RevanceGalderma
Lumenis
Solta Medical
Syneron Candela
Alma Laser
Airsculpt Technologies, Inc.
Report Attribute |
Details |
Market size value in 2023 |
USD 127.1 billion |
Revenue forecast in 2030 |
USD 332.11 billion |
Growth rate |
CAGR of 14.7% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Procedure type, gender, age group, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Swden; Norway; Denmark; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait |
Key companies profiled |
AbbVie Inc.; Cynosure; Evolus Inc.; RevanceGalderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser; Airsculpt Technologies, Inc. |
Customization scope |
Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cosmetic surgery and procedure market report based on procedure type, gender, age group, and region:
Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)
Invasive Procedures
Breast augmentation
Liposuction
Nose reshaping
Eyelid Surgery
Tummy tuck
Others
Non-invasive Procedures
Botox injections
Soft tissue fillers
Chemical peel
Laser hair removal
Microdermabrasion
Others
Gender Outlook (Revenue, USD Million, 2018 - 2030)
Male
Female
Age Group Outlook (Revenue, USD Million, 2018 - 2030)
13-29
30-54
55 and above
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
b. The global cosmetic surgery and procedure market size was estimated at USD 112.08 billion in 2022 and is expected to reach USD 127.1 billion in 2023.
b. The global cosmetic surgery and procedure market is expected to grow at a compound annual growth rate of 14.7% from 2023 to 2030 to reach USD 332.11 billion by 2030.
b. North America dominated the cosmetic surgery and procedure market with a share of 35.4% in 2022. This is attributable to increased awareness about cosmetic surgeries, their growing demand, and the easy availability of several commercialized procedures & skilled professionals in this region
b. Some key players operating in the cosmetic surgery and procedure market include Allergan plc; Merz Pharma; Cutera; Cynosure, Inc.; Ipsen; Sientra, Inc.; Alma Lasers; and Johnson & Johnson.
b. Key factors that are driving the cosmetic surgery and procedure market growth include an increase in the incidence of acne and other skin-related conditions.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."